March of Dimes Prematurity Research Center Ohio Collaborative
The March of Dimes Prematurity Research Center Ohio Collaborative announces the 2015 funding cycle for its Innovation Catalyst Grant Program. The Collaborative was established in 2013 to study the unknown causes of preterm birth. Ohio partners in the Collaborative include Cincinnati Children’s Hospital Medical Center, University of Cincinnati, Ohio State University, Nationwide Children’s Hospital, Mount Carmel Health System, Case Western Reserve University, University Hospitals and MetroHealth System of Cleveland. Dartmouth College, University of Iowa, University of South Florida, Vanderbilt University and Washington University in St. Louis are also participating sites. The Collaborative is currently focusing on five thematic areas: Evolutionary Synthesis of Human Pregnancy, Genetics of Unique Human Populations, Molecular Developmental Biology of Pregnancy, Progesterone Signaling in Pregnancy Maintenance and Preterm Birth, and Sociobiology of Racial Disparities in Preterm Birth. The Collaborative aims to foster further discovery across these thematic areas by encouraging new interactions of transdisciplinary researchers called Innovation Catalysts. A primary objective of this program is to optimize the ability of these teams to pursue new science with excellence and immediacy.
Eligibility: Open to faculty-level investigators from Collaborative sites and from other Ohio academic and medical institutions. Emphasis on state- and region-wide transdisciplinary interactions is encouraged.
The attached application should be completed which includes the following:
1. Proposal, including a Specific Aims page and up to six pages outlining the Research Strategy. Preliminary data are not required but may be included if available.
2. NIH Biosketch for principal investigator and key personnel.
3. Budget. A project period of up to 2 years may be requested. The combined budget for a two year project may not exceed $100,000 with a maximum of $50,000 requested in any single year. Faculty salaries (limited by NIH cap, up to 15% support) may be included. Only direct costs are eligible.
Application deadline is September 15, 2015. Please submit completed application to Stephanie Swart at Stephanie.Swart@cchmc.org by email as a single pdf document. Proposals will be evaluated for novelty & innovation, transdisciplinary approach and alignment with Collaborative research goals. Applicants should anticipate a response by November 6, 2015. Funding will begin January 1, 2016.
Questions may be directed to Joanne Chappell, Director of Operations, at Joanne.Chappell@cchmc.org or to Dr. Louis Muglia, Coordinating Principal Investigator, at Louis.Muglia@cchmc.org.
Clinical & Translational Science Collaborative – Career Development Training Opportunity
The Clinical & Translational Science Collaborative (CTSC) KL2 a post-doctoral training program with an emphasis on multidisciplinary clinical and translational research, offers an innovative career development opportunity for qualified candidates.
The CTSC KL2 is designed to train the nation’s future leaders in clinical and translational research, and is part of the NIH Roadmap aimed at “re-engineering the clinical research enterprise.” The CTSC KL2 has just welcomed this year’s cohort of scholars, who were selected from a highly competitive pool of applicants:
- Mohamed Abazeed, MD, PhD (Radiation Oncology; Translational Hematology & Oncology, CCF)
- Stefanie Avril, MD (Pathology, CWRU)
- Nicholas Schiltz, PhD (Epidemiology & Biostatistics, CWRU)
- Jennifer Sweet, MD (Neurosurgery, University Hospitals Case Medical Center)
CTSC KL2 is now seeking applications for next year’s cohort.
Qualified candidates must:
- Hold an MD, PhD, DDS, PharmD, PsyD, or equivalent degree
- Demonstrate a keen interest in clinical research
- Have an appointment in one of the CTSC partner institutions on or before July 1, 2016
- Be a U.S. citizen or have permanent resident status
Each scholar will embark on a 4-year program of intensive training in multidisciplinary team-based, patient-oriented clinical research, combining an innovative curriculum with mentored research experiences.
Applications will be accepted between 7/1/15 and 10/12/15.
For more information, contact Beth Spyke, MPA, at firstname.lastname@example.org / 216.444.2702 or Raed Dweik, MD, at email@example.com / 216-445-5763. You may also request to schedule an information session.
For additional information, visit the CTSC webpage.
Limited Submission Reminder: NSF Major Research Instrumentation Program (MRI)
Key Deadlines: October 5, 2015, 5:00pm (CWRU internal letter of intent), January 13, 2016, 5:00pm EST (proposal due to sponsor).
The Major Research Instrumentation Program (MRI) serves to increase access to shared scientific and engineering instruments for research and research training in our Nation's institutions of higher education, and not-for-profit museums, science centers and scientific/engineering research organizations. This program especially seeks to improve the quality and expand the scope of research and research training in science and engineering, by supporting proposals for shared instrumentation that fosters the integration of research and education in research-intensive learning environments. Each MRI proposal may request support for the acquisition (Track 1) or development (Track 2) of a single research instrument for shared inter- and/or intra-organizational use; development efforts that leverage the strengths of private sector partners to build instrument development capacity at MRI submission-eligible organizations are encouraged.
To accomplish the program's goals, the MRI program assists with the acquisition or development of a shared research instrument that is, in general, too costly and/or not appropriate for support through other NSF programs. The instrument is expected to be operational for regular research use by the end of the award period. For the purposes of the MRI program, a proposal must be for either acquisition (Track 1) or development (Track 2) of a single instrument or for equipment that, when combined, serves as an integrated research instrument (in contrast to requests for multiple instruments that enable research in a common or focused research domain, which MRI does not support). The MRI program does not support the acquisition or development of a suite of instruments to outfit research laboratories/facilities or that will be used to conduct independent research activities simultaneously.
Instrument acquisition or development proposals that request funds from NSF in the range $100,000-$4 million may be accepted from any MRI-eligible organization. Proposals that request funds from NSF less than $100,000 may also be accepted from any MRI-eligible organization for the disciplines of mathematics or social, behavioral and economic sciences and from non-Ph.D.-granting institutions of higher education for all NSF-supported disciplines.
Cost-sharing of precisely 30% of the total project cost is required for Ph.D.-granting institutions of higher education and for non-degree-granting organizations. Non-Ph.D.-granting institutions of higher education are exempt from cost-sharing and cannot include it. National Science Board policy is that voluntary committed cost sharing is prohibited.
For more information on this limited submission opportunity, visit the Office of Research Administration website.
National Multiple Sclerosis Society – Health Care Delivery and Policy Research Contracts
The National Multiple Sclerosis Society announces the following funding opportunities:
• What are the factors related to cost-escalation of MS DMT's and how does the cost of DMT's, particularly out of pocket costs, relate to access to DMT's, payer's policies concerning coverage, initiation of and adherence to therapy, and the ways in which people with MS view the value of treatment? The Society would like to fund this priority in two phases with the cost component on a fast-tracked basis and the value component as a longer-term component.
• What is the extent to which people with MS utilize complementary and alternative medicine? To what extent is this utilization part of an integrative medicine approach that combines mainstream medicine and CAM? What are the policies followed by payers for coverage of CAM independently and as part of integrative medicine?
• What are the barriers preventing access to rehabilitation services, particularly maintenance services among people with MS and what are some of the potential solutions to these barriers?
Letter of Intent Deadline: October 7, 2015
For more information visit the National MS Society webpage.
U.S. Soccer Foundation
The U.S. Soccer Foundation is accepting Letters of Inquiry for its Safe Places to Play program, which provides grants to organizations to help them build or enhance a field space in their communities. Grants of up to $50,000 will be awarded for the installation of field surfaces, lighting, and irrigation for field space in urban settings. All work must be done by one of the foundation’s four corporate partners — Hellas Construction, Musco Lighting, Hunter Industries, or Sport Court. Applicants must request a quote from the appropriate corporate partner no later than September 4, 2015.
To be eligible, an applicant must apply on behalf of a program or project operating in the U.S., and must be a tax-exempt 501(c)(3) organization, school, municipality, college or university, or sovereign tribal nation.
Letter of Intent Deadline: September 25, 2015
Application Deadline: October 2,, 2015
For more information visit the U.S. Soccer Foundation webpage.
If you have news or information that you wish to have included in this
update, please send it via e-mail to Tracy Wilson-Holden at
firstname.lastname@example.org no later than
5 pm on the Monday of the week that the update is to be distributed. If you
know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe
to Case Research News, email your request to Tora Williams at
Please note: At the time of this transmission, all links functioned.
However, Case Research News cannot guarantee that the information will not move or be